Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2015-05-21 Director's Dealing
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 220.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change (on-market trade), and dates. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transactions, which fits the definition of 'Director's Dealing' filings. The document length is 3598 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS (Director's Dealing).
2015-05-21 English
Change in substantial holding 2 pages 73.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of a substantial shareholder, including dates, number of shares, and nature of changes. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2015-05-12 English
More Penthrox Licensing Agreements Expected 2 pages 230.0KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 12 May 2015 discussing licensing agreements and distribution plans for the product Penthrox by Medical Developments International Limited. It focuses on business development activities, licensing deals, and future sales expectations. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is not a report but an announcement about licensing agreements and business updates. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is best classified as a Capital/Financing Update (CAP) because it relates to licensing agreements that impact the company's capital and future revenue streams through partnerships and distribution deals.
2015-05-11 English
Chairman Sells 7 million Shares 2 pages 224.8KB
Director's Dealing Classification · 95% confidence The document is an ASX announcement dated 12 May 2015 regarding the Chairman of Medical Developments Limited selling 7 million shares. It discusses the sale of shares by a substantial shareholder and mentions an expected notice of change of interests of a substantial shareholder. There is no financial report, earnings data, or detailed analysis. The content focuses on a transaction involving a director's shareholding. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is short and it is not an announcement of a report publication or regulatory filing. Confidence is high due to clear mention of share sale by the Chairman and expected substantial shareholder notice.
2015-05-11 English
Change of Director's Interest Notice 2 pages 220.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in relevant interests in securities, including the number of shares held before and after the change, the nature of the change (off-market trade), and other related information. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a report publication. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 3355 characters, which is consistent with a detailed insider trading notice rather than a full financial report or announcement.
2015-05-11 English
Globalisation of Penthrox 2 pages 241.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 8 May 2015 discussing the near-term planning for the globalisation of the product Penthrox. It details regulatory approvals in various countries and plans for further regulatory submissions and approvals. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (3406 characters) and serves as an update on regulatory and market expansion activities rather than a full report or financial disclosure. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a certification or officer attestation. The content is primarily an announcement about regulatory and market expansion plans, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2015-05-07 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.